Yhn HealthHealth first seen 1 d ago, last 2 min ago, peak #1

Moderna and Merck mRNA cancer vaccine cuts death and recurrence by 42%

Original: Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

Moderna and Merck report that their personalized mRNA cancer vaccine, developed for melanoma, reduced death and cancer recurrence by 42% compared with standard treatment alone. The results mark a significant milestone for mRNA technology beyond COVID-19, and the announcement is drawing wide attention as a potential turning point in personalized cancer therapy.

Why now: The companies announced major new clinical trial results showing a substantial survival benefit, a landmark moment for mRNA cancer treatment.

ModernaMerckmelanomamRNA cancer vaccine

Open on hn →

Rank over time, top of the chart is #1. 71 snapshots from 1 d ago to 2 min ago.

Evidence

• Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% · _Microft · 197
• Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% · nathcd · 6

API: https://socialmediatrends-api.osmike.com/v1/trends/3528419